BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiel MI, Schiano TD. Idiopathic noncirrhotic portal hypertension. Seminars in Diagnostic Pathology 2019;36:395-403. [DOI: 10.1053/j.semdp.2019.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Thomas C, Schiano TD, Thung SN, Ward SC, Fiel MI. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy. Histopathology 2020;76:959-67. [PMID: 31994248 DOI: 10.1111/his.14083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Imabayashi K, Nakano K, Iwata S, Tanaka Y. A case of systemic lupus erythematosus with marked ascites due to idiopathic non-cirrhotic portal hypertension. Mod Rheumatol Case Rep 2021;5:285-91. [PMID: 33783333 DOI: 10.1080/24725625.2021.1904607] [Reference Citation Analysis]
3 Seo JW, Kim ES, Han MH, Kweon YO. Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn's disease. Intest Res 2021;19:247-51. [PMID: 32610890 DOI: 10.5217/ir.2020.00016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chen IY, Whitney-Miller CL, Liao X. Congenital hepatic fibrosis and its mimics: a clinicopathologic study of 19 cases at a single institution. Diagn Pathol 2021;16:81. [PMID: 34461951 DOI: 10.1186/s13000-021-01142-y] [Reference Citation Analysis]
5 Liang J, Shi C, Dupont WD, Salaria SN, Huh WJ, Correa H, Roland JT, Perri RE, Washington MK. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 2021;34:592-602. [PMID: 32958831 DOI: 10.1038/s41379-020-00676-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ikeda D, Tsushima T, Fukumoto A, Kuzume A, Tabata R, Terao T, Miura D, Narita K, Takeuchi M, Honma K, Matsue K. Rapid liver atrophy and refractory ascites due to hepatoportal sclerosis in a patient after haploidentical stem cell transplantation. Leuk Lymphoma 2022;:1-4. [PMID: 35021928 DOI: 10.1080/10428194.2022.2027400] [Reference Citation Analysis]
7 Slowik V, Hildreth A, Pacheco MC, Finn LS, King J, Shivaram G, Files M, Hsu EK, Horslen S. Hepatopulmonary Syndrome in an Adolescent With Insidious Hypoxia and Small Intrahepatic Portal Venous Shunts: Posttransplant Benefit From Sildenafil. Pediatr Dev Pathol 2020;23:467-71. [PMID: 32813578 DOI: 10.1177/1093526620945951] [Reference Citation Analysis]
8 Kang JH, Kim DH, Kim SY, Kang HJ, Lee JB, Kim KW, Lee SS, Choi J, Lim YS. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI. Abdom Radiol (NY) 2021;46:1891-903. [PMID: 33095310 DOI: 10.1007/s00261-020-02831-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lee BT, Fiel MI, Schiano TD. Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective. J Hepatol 2021:S0168-8278(21)01957-7. [PMID: 34343613 DOI: 10.1016/j.jhep.2021.07.027] [Reference Citation Analysis]